Martine Aliana Rothblatt es una abogada y empresaria cuyo trabajo explora la intersección del derecho, la ciencia y la ética. A través de sus escritos, profundiza en preguntas profundas sobre la existencia y el progreso humanos, basándose en su amplio conocimiento tanto en los campos legal como científico. Su prosa a menudo examina las implicaciones sociales del avance tecnológico y los desafíos éticos que lo acompañan. Rothblatt desafía a los lectores a contemplar el futuro de la humanidad y nuestro papel en él.
The book presents a provocative argument for integrating Israel and Palestine into the United States, addressing potential objections with logical reasoning, historical examples, and current data. It emphasizes that this innovative approach could be crucial in alleviating the roots of terrorism within Middle Eastern politics, aiming to foster peace in a historically contentious region.
Martine Rothblatt has been at the forefront of AI research, and is a clearheaded thinker when it comes to understanding the ethical concerns that will play a role as we move towards living side by side with our mindclones. She gives us the philosophical and technological tools to understand the far-reaching implications of artificial intelligence.
This title was first published in 2003. Xenotransplantation - the transplantation of animal organs into humans - poses a fascinating moral dilemma. Should this ability to extend the lives of millions of older people be permitted given that it might trigger a new pandemic similar to AIDS? This study examines the moral dilemma from a combination of humanistic, legalistic, bioethical, economical and technological perspectives. The first part of the book demonstrates that xenografts are the only realistic near-term technological answer to the organ shortage problem. The balance of the book is devoted to assessing whether doctrines such as the 'right to health care' trump the moral and ethical conundrums posed by xenotransplantation. The book concludes with a 'geoethical' solution that proposes authorization of xenotransplantation subject to the prior implementation of a new international organization for epidemiology and basic health care. It also suggests that the costs of operating such an organization could be covered by a global tax on xenografts.
